€ 76.2
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Greatly undervalued vs peers
About
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company in Europe, the Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care. It also develops, produces, and markets products, system...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, underpriced
Target Price
The average target price of DRW3.DE is 81 and suggests 7% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
